Stocktoria
Natera, Inc. NTRA
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2015-07-02
Natera, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $1.7B | $1.1B | $820.2M | $625.5M |
| R&D expense | $624.1M | $404.1M | $320.7M | $316.4M | $264.2M |
| SG&A expense | $1.2B | $841.3M | $618.3M | $588.6M | $511.0M |
| Operating income | -$309.9M | -$222.3M | -$446.2M | -$541.0M | -$468.2M |
| Interest expense | $4.1M | $10.7M | $12.6M | $9.3M | $8.3M |
| Income tax | -$59.9M | $695,000 | $271,000 | $978,000 | $618,000 |
| Net income | -$208.2M | -$190.4M | -$434.8M | -$547.8M | -$471.7M |
| EPS (diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
| Operating cash flow | $215.3M | $135.7M | -$247.0M | -$431.5M | -$335.2M |
| Free cash flow | $109.1M | $69.2M | -$286.2M | -$479.2M | -$376.3M |
| Cash & equivalents | — | — | — | $466.0M | $84.4M |
| Inventory | $68.4M | $44.7M | $40.8M | $35.4M | $26.9M |
| Total assets | $2.4B | $1.7B | $1.4B | $1.4B | $1.2B |
| Total liabilities | $685.9M | $465.3M | $676.4M | $688.7M | $583.2M |
| Shareholders' equity | $1.7B | $1.2B | $765.3M | $705.7M | $653.3M |
Source: SEC EDGAR filings · CIK 0001604821 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.